InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 13.70
-0.78 (-5.39%)
Sep 10, 2026, 11:44 AM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 29.73 billion as of September 9, 2026. Its market cap has decreased by -11.63% in one year.
Market Cap
29.73B
Enterprise Value
23.22B
Revenue
3.21B
Ranking
n/a
PE Ratio
24.82
Stock Price
13.70
ChartMarket Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 29.73B, an increase of 142.15%. That is a compound annual growth rate of 14.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 29.73B | 25.52% |
| Dec 31, 2025 | 23.69B | 93.83% |
| Dec 31, 2024 | 12.22B | -6.80% |
| Dec 29, 2023 | 13.11B | -44.09% |
| Dec 30, 2022 | 23.45B | 11.18% |
| Dec 31, 2021 | 21.09B | 21.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genscript Biotech | 67.79B |
| RemeGen | 67.07B |
| Biocytogen Pharmaceuticals (Beijing) | 53.26B |
| 3SBio | 39.98B |
| Shanghai Henlius Biotech | 35.63B |
| Shanghai Junshi Biosciences | 33.90B |
| InSilico Medicine Cayman TopCo | 27.44B |
| Zai Lab | 23.09B |